How Discovery Fast Track works

Questions to ask before you enter:

Do you have a clear therapeutic hypothesis?

We are looking for a coherent and supportable hypothesis to develop a medicine that would provide therapeutic benefit to particular groups of patients.

Do you have a defined target?

You should have identified a specific protein drug target linked to a disease and be able to propose why modulating this with a small molecule could provide an effective and safe therapy.

Do you have enabling expertise?

The 2016 Discovery Fast Track UK Golden Triangle Challenge is a collaboration. You should have generated data which provides proof of concept for your proposal and, ideally, already have developed key reagents and assays.

If you answered “yes” to the above questions, then the 2016 Discovery Fast Track UK Golden Triangle Challenge is a great opportunity for you. If you wish to propose a biological as a therapeutic, you may want to reach out to GSK’s Discovery Partnerships with Academia (DPAc) team. If you wish to propose a vaccine, technology or delivery system, see these other opportunities at GSK Partnerships. For proposals centred on tropical diseases, explore our partnerships for neglected tropical diseases.

Workflow for 2016 Discovery Fast Track UK Golden Triangle Challenge

chart: Workflow for Discovery Fast Track UK Golden Triangle Challenge

The submission process.

Once the screen is complete, four research outcomes are possible.

To get started, create your Discovery Fast Track account.